Psilocybin, AI as Personalised, Complementary Therapy

This week on The Real Life Lab, I sit down with Mark A. Michaels, a lawyer, writer, and self-described "uncontrolled experiment" (he's part of the first generation of donor-conceived people from the 1950s). Mark recently completed a client-authored case study on psychedelic-assisted therapy, combining EMDR, ketamine, MDMA, psilocybin, creative expression, and AI-assisted reflection, all in collaborative therapy aimed at reclaiming what he calls "narrative agency."We talk about what actually happened in those sessions, what AI's role really was versus what a human clinician offers, and what it means to become the author of your own healing instead of just the subject of it. This is a raw, honest look at a very unconventional path through a hard chapter, told by the person who lived it.This is not a path for everyone, as Mark A. Michaels says, but with AI growing daily, it presents both challenges and opportunities. Note: This episode discusses psychedelic-assisted therapy as part of Mark's personal healing process. It reflects his experience only and isn't medical guidance.